deltatrials

Institut National de la Santé Et de la Recherche Médicale, France Clinical Trials

Sponsors / Institut National de la Santé Et de la Recherche Médicale, France

According to ClinicalTrials.gov, Institut National de la Santé Et de la Recherche Médicale, France has served as lead sponsor on 448 registered trials. 80 trials are actively recruiting participants, 16 remain active without open enrollment, and 266 have concluded. 31 of these trials ended early via termination or withdrawal. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. The cumulative planned enrollment figure across all listed trials is 677,667 participants. All figures are drawn directly from ClinicalTrials.gov and updated as sponsors submit revisions.

448
Total Trials
80
Recruiting
16
Other Active
266
Completed
31
Terminated / Withdrawn
677,667
Total Enrollment

Termination reasons: Other61% · Recruitment23% · Efficacy6% · Business3% · Funding3% · Regulatory3%

Recent Terminations

  • NCT03576248 Phase NA Stopped Jan 2024
    Disorder of Consciousness
    "Expected number of patients unreached because of COVID19 pandemics. Inclusion stopped at N=20 patients (lower expected number of patients)."
  • NCT04322279 Stopped Dec 2022
    Coronavirus
    "no topics to include"
  • NCT03827759 Stopped Jul 2022
    Children
    "End of the inclusion period and difficulty in recruiting the youngest patients"
  • NCT04238871 Stopped Jan 2022
    Idiopathic Interstitial Pneumopathy/Pneumopathy Interstitial Diffuse
    "Regulatory requalification en C20-58"
  • NCT03708263 Phase NA Stopped Sep 2021
    Erythematotelangiectatic Rosacea
    "departure of Pr MORDON from the ONCOTHAI unit"
  • NCT04005833 Stopped Jun 2021
    Chronic Obstructive Pulmonary Disease
    "Inclusions were suspended due to the COVID-19 pandemic, and the inclusion rate would not increase during the resumption."
  • NCT03364010 Phase NA Stopped Jun 2021
    Dyslexia
    "END OF INCLUSIONS"
  • NCT02878083 Phase NA Stopped Jan 2021
    ULCERATIVE COLITIS
    "the CELLVIZIO device required to analyse biopsy is available until september 2020"
  • NCT03771144 Phase NA Stopped Jun 2020
    Brachial Obstetrical Palsy
    "Investigator's decision"
  • NCT05976958 Stopped Aug 2019
    Periodic Paralyses
    "The study planed to collect data via a smartphone application that was never developed"

Active Trials (16 total)

Top Conditions

Top Locations